13May 2018

VERNEUILS DISEASE.

  • Department of Plastic and Reconstructive Surgery in CHU Mohamed VI, Marrakech, Morocco.
  • Department of Dermatology in CHU Mohamed VI, Marrakech, Morocco.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Verneuil\'s disease is a chronic fistulating, sclerosing and scar-forming suppuration. Its diagnosis is often misunderstood and therefore mistaken for another pathology. Through the analysis of 13 observations of Verneuil\'s disease, we wanted to take stock of the clinical diagnosis, the ethiopathogenesis and the therapeutic principles of this disease. Descriptive retrospective study including all hospitalized patients in the plastic surgery department of CHU Mohammed VI in Marrakech Morocco for a Verneuil?s disease, from January 2009 to December 2015. The characteristics of the disease and the therapeutic proposal were analyzed and the effectiveness and satisfaction of the surgical treatment evaluated. In 6 years, 13 patients (10 men and 3 women) with an average age of 43.8 years were hospitalized in our department. Smoking was present in six of our patients ie 46% of our active smoking-type patients with an average of 31.1 years packs. The mean age of onset of the disease for women was 24.2 years and 30.6 years for men. The average diagnosis time for the disease was 9.32 years with extremes of 2 months and 43 years, the diagnosis was carried by a dermatologist in the majority of cases. The average body mass index value of patients in our series is 25.78 kg / m2 with extreme values of 20.2 and 31.1 kg / m?, which corresponds to an overweight. The most common localization is axillary localization followed by gluteal localization. Hurley\'s score varied between 3 grades with a predominance of grade 3 for the 34 territories reached for our 13 patients. Two of our patients had ulcerated-budding lesions with irregular edges on scar placards, in whom the cutaneous biopsy demonstrated a squamous cell carcinoma. Eleven patients had a total lesion excision, unlike partial excision, which has never been performed for any of these patients. Two patients underwent carcinological tumor excision with lymph node dissection for squamous cell carcinoma. The type of cover that has been most used in this series is the direct suture. Skin transplantation by thin skin was performed for 7 territories in 6 patients with a delay of 3.5 months, with extreme values of 2 and 6 months. The territories where the skin graft was carried out are the gluteus territory to the number of 4 and the axillary territory to the number of 3. The directed healing was carried out for the two patients who benefited from a carcinological excision. The complications found in our patients 1 cases of haemorrhage, 1 case of perioperative recurrence, 1 case of sequellar bridle, 2 cases of hypertrophic scar, 2 cases of persistent pain. The satisfaction of the surgical treatment could be evaluated in postoperative with a follow-up of more than 9 months in 7 patients who are satisfied with the surgical treatment. At a time, when new molecules have been developed and studied for the treatment of Verneuil\'s disease, surgical excision remains a treatment of choice in some situations. Medico-surgical discussion is essential for the management of this disease and its development must be a priority.


  1. Gregor B.E. Jemec, Jean Revuz, James J. LeydenHidrad?nitesuppur?e, Edition Springer 2008, Ch 10.1,
  2. The symptomatology of hidradenitissuppurativa in women.Br J Dermatol. 1988 Sep;119(3):345?50.
  3. Hidradenitissuppurativa.JEurAcadDermatolVenereol. 2009 Sep;23(9):985?98.
  4. Verneuil A.Etudes sur les tumeurs de la peau ; de quelques maladies des glandes sudoripares.ArchGen Med. 1854;(4):447?68.
  5. Bassukas ID, HundeikerM.Acneinversa (pyodermiafistulanssinifica) and smoking.
  6. J Am AcadDermatol. 1997 Jun;36(6 Pt 1):1029.
  7. BelhabibMaladie de Verneuil?: A propos de 107 cas,Rabat?,2012
  8. Bordier-Lamy Maladie de Verneuil?: Etude r?trospective chez 93 malades trait?s chirurgicalement ,2008
  9. Vilchez-Marquez et alEpidemiology of Hidradenitissuppurativa in Spain?: Analysis of ethnic differences in the city of Ceuta, 2015
  10. Kathleen McMillan et al HidradenitisSuppurativa: Number of Diagnosed Patients, Demographic Characteristics, and Treatment Patterns in the United States, ,2014
  11. Whan B. Kim Clinical Features and Patient Outcomes of HidradenitisSuppurativa: A Cross-Sectional Retrospective Study, ,2015
  12. Xu et alPhenotype of 53 chinese individuals with nicastrin gene mutations in association with familial hidradenitissuppurativa (Acne inversa), 2015,
  13. IchiroKurokawa et alQuestionnaire surveillance of hidradenitissuppurativa in Japan, ,2015
  14. Bieniek A, Matusiak L, Okulewicz-Gojlik D, SzepietowskiJC.Surgical treatment of hidradenitissuppurativa: experiences and recommendations.
  15. Dermatol Surg. 2010 Dec;36(12):1998?2004.
  16. Diane Guedes De Carvalho Prise en charge de la maladie de Verneuil au d?cours de la consultation m?dico-chirurgicale de dermatologie du CHRU de Lille : ?tude r?trospective de janvier 2009 ? d?cembre 2015,
  17. Kromann CB, Ibler KS, Kristiansen VB, JemecGB.The influence of body weight on the prevalence and severity of hidradenitissuppurativa. ActaDermVenereol. 2014 Sep;94(5):553?7.
  18. Clio Dessinioti MD, ChrisaZisimou MD, VassilikiTzanetakou,A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativa,1st Departement of Dermatology, A. syggros Hospital, University of Athens, Athens, Greece , 4 January 2017?.
  19. Esmann S, JemecGB.Psychosocial impact of hidradenitissuppurativa: a qualitative study.ActaDermVenereol. 2011 May;91(3):328?32.
  20. Kurek A, Peters EM, Chanwangpong A, Sabat R, Sterry W, Schneider-Burrus S.
  21. Profound disturbances of sexual health in patients with acne inversa.J Am AcadDermatol. 2012 Sep;67(3):422?428, 428.e1
  22. Theut Riis, L. Thorlacius, E.L. Knudsen, G.B.E. JemecA pilot study of unemployment in HidradenitisSuppurativa Patients in Denmark?, 2016?,
  23. Matusiak L, Bieniek A, Szepietowski JC. Hidradenitissuppurativa markedly decreases quality of life and professional activity.J Am AcadDermatol. 2010;62(4):706-8, 8 e1.
  24. Gregor B.E. Jemec, Jean Revuz, James J. LeydenHidrad?nite suppur?e,
  25. Edition Springer 2008, Ch 10.1,
  26. Tzellos T, Zouboulis CC, Gulliver W, Cohen AD, Wolkenstein P, Jemec GB.
  27. Cardiovascular disease risk factors in patients with hidradenitissuppurativa: a systematic review and meta-analysis of observational studies.
  28. Br J Dermatol. 2015 Nov;173(5):1142?55.
  29. Sartorius K, Emtestam L, Jemec GB, Lapins J.
  30. Objective scoring of hidradenitissuppurativa reflecting the role of tobacco smoking and obesity.Br J Dermatol.2009 Oct;161(4):831?9.
  31. Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al.Clinical characteristics of a series of 302 French patients with hidradenitissuppurativa, with an analysis of factors associated with disease severity.
  32. J Am AcadDermatol. 2009 Jul;61(1):51?7.
  33. Schrader AMR, Deckers IE, van der Zee HH, Boer J, Prens EP.
  34. Hidradenitissuppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity.J Am AcadDermatol. 2014 Sep;71(3):460?7.
  35. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al.
  36. Prevalence and factors associated with hidradenitissuppurativa: results from two case-control studies.J Am AcadDermatol. 2008 Oct;59(4):596?601.
  37. Kromann CB, Deckers IE, Esmann S, Boer J, Prens EP, Jemec GB.
  38. Risk factors, clinical course and long-term prognosis in hidradenitissuppurativa: a cross-sectional study.Br J Dermatol. 2014 Oct;171(4):819?24.
  39. Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, et al.
  40. Increased prevalence of metabolic syndrome in patients with acne inversa.
  41. PLoS ONE. 2012;7(2):e31810.
  42. Gold DA, Reeder VJ, Mahan MG, HamzaviIH.The prevalence of metabolic syndrome in patients with hidradenitissuppurativa.
  43. J Am AcadDermatol. 2014 Apr;70(4):699?703.
  44. Yadav S, Singh S, EdakkanambethVarayil J, Harmsen WS, Zinsmeister AR, Tremaine WJ, et al.HidradenitisSuppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
  45. 2016 Jan;14(1):65?70
  46. Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD.Psychiatric comorbidities in 3207 patients with hidradenitissuppurativa.JEurAcadDermatolVenereol. 2015 Feb;29(2):371?6.
  47. Hsiao JL, Antaya RJ, Berger T, Maurer T, Shinkai K, Leslie KS.Hidradenitissuppurativa and concomitant pyodermagangrenosum: a case series and literature review.
  48. Arch Dermatol. 2010 Nov;146(11):1265?70.
  49. Powell FC, Schroeter AL, Su WP, Perry HO.Pyodermagangrenosum: a review of 86 patients.Q J Med. 1985 May;55(217):173?86.
  50. Richette P, Molto A, Viguier M, Dawidowicz K, Hayem G, Nassif A, et al.Hidradenitissuppurativa associated with spondyloarthritis -- results from amulticenter national prospective study.JRheumatol. 2014 Mar;41(3):490?4.
  51. Legrand E, Audran M, Rousselet-Chapeau MC (1995) Le Levier F, Brithmer L,Vigouroux B, Pidhorz L, Br?geonC.Iliacosteosarcoma in a patient with SAPHO syndrome.
  52. Rev RhumEngl Ed 62(2): 139
  53. Von der Werth JM, Williams HC.The natural history of hidradenitissuppurativa.
  54. J EurAcadDermatolVenereol. 2000 Sep;14(5):389?92.
  55. Saunte DM, Boer J, Stratigos A, Szepietowski JC, Hamzavi I, Kim KH, et al.
  56. Diagnostic delay in hidradenitissuppurativa is a global problem.Br J Dermatol. 2015 Dec;173(6):1546?9.
  57. Alikhan A, Lynch PJ, EisenDB.Hidradenitissuppurativa: a comprehensive review.
  58. J Am AcadDermatol. 2009 Apr;60(4):539?561; quiz 562?563.
  59. Kromann CB, Ibler KS, Kristiansen VB, JemecGB.The influence of body weight on the prevalence and severity of hidradenitissuppurativa. ActaDermVenereol. 2014 Sep;94(5):553?7.
  60. Ostler LS, Langtry JAA, Mortimer PS, StaughtonRCD.Hidradenitissuppurativa in Crohn?s didease. Br J Dermatol 1991; 125: 384-6
  61. Pedras J, DaudenE.Practical management of Hidradenitissuppurativa.ActasDermosifiliogr 2008;99:101?110
  62. Ritz JP, Runkel N, Haier J, BuhrHJ.Extent of surgery and recurrence rate of hidradenitissuppurativa.Int J Colorectal Dis. 1998;13:164-8. 59.
  63. Rubin RJ, Chinn BT (1994)Perianal hidradenitissuppurativa.SurgClin North Am 74: 1317-25*
  64. Gangloff , G.-E. Ferron , I. Garrido , G. Fabre , P. Martel , D. Querleu , J.-P. Chavoin, J.-L. Grolleau-RaouxReconstructionp?lvip?rineale. EMC (Elsevier SAS , Paris) , Techniques chirurgicales -Chirurgie plastique reconstructrice et esth?tiques 2006, 45-685
  65. Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juh?sz I, et al.
  66. European S1 guideline for the treatment of hidradenitissuppurativa/acne inversa.
  67. J EurAcadDermatolVenereol. 2015 Apr;29(4):619?44.
  68. Alharbi Z, Kauczok J, Pallua N.A review of wide surgical excision of hidradenitissuppurativa.BMCDermatol. 2012;12:9
  69. Bocchini SF, Habr-Gama A, Kiss DR, Imperiale AR, Araujo SE.Gluteal and perianal hidradenitissuppurativa: surgical treatment by wide excision.Dis Colon Rectum. 2003 Jul;46(7):944?9.
  70. Molnar C, Hevessy Z, Rozgonyi F et al. (1994)Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence, hydrophobicity, and toxin production in vitro.JClinPathol 47: 743-8
  71. Faye O, Petit F, Poli F, Petit T, Wechsler J, Gabison G, et al.Lymphoed?me compliquant une hidrad?nite suppur?e : trois observations. Ann DermatolVenereol. 2007 Jul;134(6-7):567?9.
  72. Moosbrugger EA, Mutasim DF.
  73. Hidradenitissuppurativa complicated by severe lymphedema and lymphangiectasias.
  74. J Am AcadDermatol. 2011 Jun;64(6):1223?4.
  75. Good LM, Francis SO, High WA.
  76. Scrotal elephantiasis secondary to hidradenitissuppurativa.
  77. J Am AcadDermatol. 2011 May;64(5):993?4.
  78. Alice Verdelli, MD Emiliano Antiga,A fatal case of hidradenitissuppurativa associated with sepsis and squamous cell carcinoma?,Dermatology Section Department of Surgery and Translational Medicine University of Florence Florence Italy
  79. NatanelJourabchi, Alexander H Fischer, Ashley Cimino-Mathews, Kevin M Waters &Ginette A Okoye,Squamous cell carcinoma complicating a chronic lesion of hidradenitissuppurativa : a case report and review of the literature, Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA?,2016
  80. JC Talmant et alD?g?n?rescence de la maladie de Verneuil en carcinome epidermoide?: A propos de deux cas et revue de la litt?rature, Service de chirurgie maxillo-facial, Hopital civil, Strasbourg.
  81. Guet-Revilleta, S. Poir?eb, et al,Microbiologie de l?hidrosad?nite suppur?e: une ?tude sur 102l?sionsH. h?pital Necker-Enfants malades, Paris, France, 2011.
  82. Li M,HuntMJ,Commens CA (1997) Hidradenitissuppurativa, Dowling Degos disease and perianal squamous cell carcinoma. Australas J Dermatol 38(4): 209-11
  83. Bocchini SF, Habr-Gama A, Kiss DR, Imperiale AR, Araujo SE.
  84. Gluteal and perianal hidradenitissuppurativa: surgical treatment by wide excision.
  85. Dis Colon Rectum. 2003 Jul;46(7):944?9.
  86. Soldin MG, Tulley P, Kaplan H, Hudson DA, GrobbelaarAO.Chronic axillary hidradenitis--the efficacy of wide excision and flap coverage. Br J Plast Surg. 2000 Jul;53(5):434?6.
  87. Busnardo FF, Coltro PS, Olivan MV, Busnardo APV, Ferreira MC.Thethoracodorsal artery perforator flap in the treatment of axillary hidradenitissuppurativa: effect on preservation of arm abduction.PlastReconstr Surg. 2011 Oct;128(4):949?53
  88. Van Hattem S, Spoo JR, Horv?th B, Jonkman MF, Leeman FW. Surgical treatment of sinuses by deroofing in hidradenitissuppurativa. Dermatol Surg. 2012 Mar;38(3):494?7.
  89. Rompel R, PetresJ.Long-term results of wide surgical excision in 106 patients with hidradenitissuppurativa. Dermatol Surg. 2000 Jul;26(7):638?43.
  90. Harrison BJ, Mudge M, Hughes LE.Recurrence after surgical treatment of hidradenitis suppurativa.Br Med J Clin Res Ed. 1987 Feb 21;294(6570):487?9.
  91. Harrison BJ, Mudge M, Hughes LE. Recurrence after surgical treatment of hidradenitis suppurativa.Br Med J Clin Res Ed. 1987 Feb 21;294(6570):487?9.
  92. Mehdizadeh A, Hazen PG, Bechara FG, Zwingerman N, Moazenzadeh M, Bashash M, et al.
  93. Recurrence of hidradenitissuppurativa after surgical management: A systematic review and meta-analysis.
  94. DeFazio MV, Economides JM, King KS, Han KD, Shanmugam VK, Attinger CE, et al.
  95. Outcomes After Combined Radical Resection and Targeted Biologic Therapy for the Management of Recalcitrant HidradenitisSuppurativa.AnnPlast Surg. 2015 Nov 10;
  96. Ritz JP, Runkel N, Haier J, BuhrHJ.Extent of surgery and recurrence rate of hidradenitissuppurativa.Int J Colorectal Dis. 1998;13(4):164?8.

[Ouafaa Dhaidah, Sara Zahid, Abdelkodus Bhihi, Mehdi Sahibi, Adil Dehhaze, Mariem Quaboul, MoulayDriss Elamrani, Yassine Benchamkha and Salwa Ettalbi. (2018); VERNEUILS DISEASE. Int. J. of Adv. Res. 6 (May). 10-22] (ISSN 2320-5407). www.journalijar.com


Ouafaa Dhaidah
Plastic Surgery Department

DOI:


Article DOI: 10.21474/IJAR01/7004      
DOI URL: http://dx.doi.org/10.21474/IJAR01/7004